Explore the complexities of malaria vaccine development, targeting Plasmodium species/stages, immunity evidence, and broad vaccine approaches focusing on sub-unit vaccines. Discover the quest for an effective and accessible malaria vaccine.

7 views • 32 slides

Shirebrook, a deprived area in Derbyshire, has been grappling with health inequalities and vaccine hesitancy, particularly among certain groups like ethnic minorities and those living in deprivation. Efforts have been made to engage the community, resulting in varying levels of vaccine uptake among

1 views • 14 slides

This content provides updates on infectious disease prevention efforts, including historical data, TB data posting schedule, and HIV surveillance updates. It also highlights the plans of the US Department of Health and Human Services to produce 4.8 million doses of the H5N1 avian flu vaccine for pan

0 views • 7 slides

This training module aims to equip health workers with the skills to address vaccine hesitancy effectively. It covers identifying hesitant individuals, engaging in conversations to build trust, and responding to concerns using motivational interviewing. Factors contributing to vaccine hesitancy and

1 views • 44 slides

Congratulations on your infant reaching 2 months! Learn about the importance of vaccines and how to make informed decisions regarding vaccinating your baby. Access valuable resources from CDC to understand vaccine benefits and risks. Still unsure? Get familiar with vaccine-preventable diseases and h

0 views • 14 slides

Polio, a disabling disease caused by the poliovirus, mainly affects children and can lead to paralysis. Efforts to eradicate polio include the development of vaccines like the Inactivated Polio Vaccine (IPV) and Oral Polio Vaccine (OPV). The poliovirus' choice of host, ease of transmission, and impa

0 views • 15 slides

The UK has approved Moderna as the third Covid vaccine, with logistical challenges due to required storage at -75C. AstraZeneca's vaccine is easier to distribute. Moderna offers nearly 95% protection from severe Covid, but all vaccines require a second dose for optimal immunity. Uncertainty remains

0 views • 7 slides

The Republic of Zimbabwe is gearing up for the introduction of a COVID-19 vaccine as part of its response to the pandemic, with a focus on deploying 200,000 doses to priority groups. The comprehensive plan includes key strategies, financing alignment, and integration into national governance mechani

5 views • 28 slides

BCG vaccine, a live attenuated vaccine, protects against tuberculosis with varying efficacy. It is administered intradermally in the left upper arm, leaving a characteristic scar. Adverse reactions are generally mild, but contraindicated in immunodeficiency or HIV infection.

0 views • 12 slides

This informative content delves into vaccine safety, effectiveness, and side effects, offering insights into the development stages of vaccines, COVID-19 vaccine comparisons, and an overview of COVID-19 vaccine development. It also explains how vaccines work to protect against viruses and emphasizes

0 views • 33 slides

This installation guide provides step-by-step instructions for installing the probe of the VFC-400 Vaccine Monitoring Data Logger Kit in a fridge or freezer. The guide includes details on placing the probe, routing the cable, securing with zip ties, and mounting the logger for efficient monitoring.

0 views • 5 slides

Specific populations have unique concerns regarding vaccine hesitancy. Effective communication strategies, such as approaching conversations with curiosity, seeking permission, and validating emotions, can help address reluctant attitudes towards COVID-19 vaccines. Healthcare professionals provide v

0 views • 20 slides

This review delves into the issue of vaccine hesitancy across prisons, aiming to provide recommendations to address the decline in vaccination rates. Utilizing data from 20 sites with high decline rates and 5 sites with high uptake rates, the analysis examines factors like geography, ethnicity, and

0 views • 13 slides

This presentation provides a detailed guide on operating the VFC-400 Vaccine Monitoring Data Logger Kit. It covers essential functions like entering review mode, starting and stopping recording, and monitoring temperature data. The step-by-step instructions ensure accurate temperature logging for va

0 views • 9 slides

An 84-year-old female presented with fever, SOB, fatigue, and diarrhea after receiving a COVID-19 vaccine. Despite initial improvement with antibiotics, she developed liver abscess, highlighting the complexity of diagnosing post-vaccination symptoms. Clinicians should remain vigilant and consider al

0 views • 5 slides

The update discusses the latest information on Pfizer's COVID-19 vaccine, including details on the new technology, storage requirements, logistics handling, and Emergency Use Authorization (EUA). Pfizer's vaccine, with a 95% efficacy rate, requires storage in ultra-low-temperature freezers or therma

0 views • 28 slides

Dr. Chizoba Wonodi is evaluating the use of co-created messages and trusted messengers to improve COVID-19 vaccine acceptance in Northern Nigeria. Vaccine hesitancy due to conspiracy theories and safety concerns remains a challenge. TM-COVAC study aims to design targeted messages using human-centere

0 views • 8 slides

In the latest VASE+ Release 11.4, several new features have been introduced to enhance vaccine management processes. These include a new vaccine selection field, Pfizer vaccine lot addition for 5-11-year-olds, color coding per vaccine type, customizability options, new columns for vaccine name and s

0 views • 8 slides

This content provides valuable information on handling vaccines, including determining vaccine viability, identifying wastage, and understanding expiration dates. It includes scenarios covering vaccine storage, reporting spoiled doses, and managing vial wastage. The answers and explanations offered

0 views • 7 slides

This presentation focuses on the significance of vaccine wastage in the context of measles elimination, emphasizing the factors influencing wastage, why it matters for achieving high vaccination coverage, and tools for estimating wastage. The content highlights the challenges posed by wastage on vac

0 views • 13 slides

Nimrod Muhumuza, from Afya na Haki Institute, presents a critical analysis of vaccine plant setup in Rwanda and Uganda. The discussion focuses on the potential leadership roles of small economies, private sector involvement, sustainability of vaccine production, and the importance of participation f

0 views • 13 slides

The study explores the impact of Efgartigimod, a Neonatal Fc Receptor blocker, on humoral vaccine responses in patients with autoimmune diseases. It discusses how immunosuppressive therapies used in autoimmune disorders may affect susceptibility to infections and impair vaccine immunogenicity, highl

0 views • 18 slides

The Illinois Department of Corrections emphasizes the importance of the COVID-19 vaccine, highlighting its effectiveness in preventing severe illness. Individuals are encouraged to make an informed decision about vaccination, ensuring protection for themselves and others. The department assures that

0 views • 52 slides

The Oxford-AstraZeneca vaccine has shown a likely but unproven link to cerebral venous sinus thrombus and other blood clotting issues. Despite this, the benefits of vaccination still outweigh the risks, with only approximately 4 cases per million resulting in death. Communication of the potential be

0 views • 10 slides

A presentation of key findings and recommendations from the Vaccine Engagement Teams (VETs) Evaluation in July 2022, highlighting increased vaccine confidence, effective ambassador outreach, and innovative community health programming. The evaluation assessed the VETs' achievements, identified barri

0 views • 19 slides

In this update, Tennessee reports an increase in COVID-19 vaccine uptake with 52.8% having at least one dose and 46.7% fully immunized. The state ranks 40th in vaccine administration per 100K population. Vaccine hesitancy is addressed, and dates of FDA committee meetings on booster authorizations an

0 views • 15 slides

This presentation discusses the history of vaccine liability and legal battles in the United States, covering events such as the Cutter Incident, the Swine Flu vaccine campaign, and cases like Berkovitz v. U.S. It explores the challenges, consequences, and legal defenses surrounding vaccine-related

0 views • 25 slides

Pfizer and Moderna vaccine updates for different age groups, Novavax administration, clinical updates, and myocarditis/pericarditis updates were discussed in the Alpha Office Hours meeting scheduled for June 16, 2022. The agenda also included Vaccine Finder and July 4th shipping updates. The timelin

0 views • 31 slides

The Southern COVID Vaccination Programme offers resources for providers to reach 90% vaccination by Christmas. The campaign encourages community-based initiatives to protect loved ones through accessibility, addressing hesitancy, and overcoming barriers. Key messages focus on increasing vaccination

0 views • 32 slides

The Michigan COVID-19 Survey conducted in March 2021 provides valuable insights on vaccine segments, key findings, and likelihood to get the vaccine among residents aged 16 and older. The survey categorizes individuals into Vaccine Definites, Persuadables, and Nevers, highlighting that 61% are firml

1 views • 10 slides

Discussing factors influencing COVID-19 vaccine acceptance, surveys on hesitancy, perspectives of older adults, and strategies for addressing concerns. Details on Pfizer and Moderna vaccines, efficacy data, side effects, and subgroup analyses are provided.

0 views • 17 slides

Edward Jenner, a renowned figure in medical history, was born on May 17, 1749. He made significant contributions to immunology by developing the smallpox vaccine. His pioneering work involved inoculating individuals with cowpox to confer immunity against smallpox, a disease that was highly feared fo

0 views • 13 slides

This job aid explains how Site Admins can add, edit, and manage vaccine inventory lots for clinics. Users can add new vaccine lots, edit existing entries, and associate vaccine lots with specific clinics in the system. The process involves entering lot details, NDC code, expiration, and available do

0 views • 4 slides

The Global Vaccine and Immunization Research Forum 2023, scheduled for March 28-30 at Grand Hyatt, Incheon, Korea, will feature keynote speakers, plenary sessions, workshops, and discussions on various topics related to vaccine research, development, and global health. The agenda includes sessions o

0 views • 9 slides

This presentation, developed by CDC's COVID-19 Response Vaccine Task Force and Homelessness Unit, focuses on COVID-19 vaccination basics, safety, prioritization for individuals experiencing homelessness, and strategies to overcome barriers to vaccination. It highlights the importance of understandin

0 views • 49 slides

Learn how to efficiently create clinic schedules in VASE+ system for managing appointments, vaccine information, and site details. Explore step-by-step guidance on setting clinic name, contact points, timing, intervals, and vaccine details. Users with specific roles in the system can easily create s

0 views • 4 slides

New updates regarding COVID-19 vaccine administration and recommendations have been released, including the ability for clinics to create and manage vaccine supplies for children as young as six months. The Western States Scientific Review Workgroup supports the use of Moderna and Pfizer-BioNTech bi

0 views • 6 slides

Updates on COVID-19 vaccine distribution and administration in Oklahoma, including the number of doses administered, individuals partially and fully vaccinated, and guidance on booster doses and addressing vaccine hesitancy. The data reflects information as of June 21, 2022. Highlights include the t

0 views • 40 slides

The NC COVID-19 Vaccine Plan discussed in the October 9, 2020 Task Force Meeting includes details on vaccine supply, distribution goals, clinical trial timelines, safety, and outreach strategies. Key points cover vaccine development progress, trial protocols, distribution targets, and communication

0 views • 6 slides

Phase 3 data of the BNT162b2 mRNA Covid-19 vaccine, including study design, participant groups, primary endpoints, and key findings regarding safety and efficacy. The vaccine demonstrated efficacy against confirmed Covid-19, with reported local and systemic adverse effects within a specified timefra

0 views • 48 slides